A mixed methods study of age at diagnosis and diagnostic odyssey for Duchenne muscular dystrophy

被引:38
|
作者
Wong, Siaw H. [1 ,2 ]
McClaren, Belinda J. [1 ]
Archibald, Alison Dalton [1 ,2 ,3 ]
Weeks, Alice [1 ]
Langmaid, Tess [1 ]
Ryan, Monique M. [1 ,2 ,4 ]
Kornberg, Andrew [1 ,2 ,4 ]
Metcalfe, Sylvia A. [1 ,2 ]
机构
[1] Murdoch Childrens Res Inst, Parkville, Vic, Australia
[2] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia
[3] Victorian Clin Genet Serv, Parkville, Vic, Australia
[4] Royal Childrens Hosp, Dept Neurol, Parkville, Vic 3052, Australia
关键词
EXPERIENCES; EXPLORATION; THERAPY; PARENTS; BOYS;
D O I
10.1038/ejhg.2014.301
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The delayed diagnosis of Duchenne muscular dystrophy (DMD) may be an ongoing problem internationally. We aimed to ascertain age at diagnosis and explore parents' experiences of the diagnosis of DMD in Australia. Using mixed methods, data were collected from laboratory and clinical record audits of testing for DMD in Victoria and Tasmania, interviews and a national survey of parents regarding their experiences from first noticing symptoms to receiving a diagnosis. The audits revealed that the median age at diagnosis for DMD was 5 years (n = 49 during 2005-2010); this age had not changed substantially over this period. Fourteen parents interviewed reported age at diagnosis ranging from 2 to 8 years with a 6 month to 4 year delay between initial concerns about their child's development and receiving the DMD diagnosis. Sixty-two survey respondents reported the median age at diagnosis was 3 years and 9 months, while the median age when symptoms were noticed was 2 years and 9 months. Parents experienced many emotions in their search for a diagnosis and consulted with a wide range of health professionals. Half the survey respondents felt that their child could have been diagnosed earlier. Despite advances in testing technologies and increasing awareness of DMD, the age at diagnosis has remained constant in Australia. This mixed methods study shows that this diagnostic delay continues to have a negative impact on parents' experiences, places families at risk of having a second affected child and may have a deleterious effect on affected children's treatment.
引用
收藏
页码:1294 / 1300
页数:7
相关论文
共 50 条
  • [21] Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements
    D'Amico, Adele
    Catteruccia, Michela
    Baranello, Giovanni
    Politano, Luisa
    Govoni, Alessandra
    Previtali, Stefano Carlo
    Pane, Marika
    D'Angelo, Maria Grazia
    Bruno, Claudio
    Messina, Sonia
    Ricci, Federica
    Pegoraro, Elena
    Pini, Antonella
    Berardinelli, Angela
    Gorni, Ksenjia
    Battini, Roberta
    Vita, Gianluca
    Trucco, Federica
    Scutifero, Marianna
    Petillo, Roberta
    D'Ambrosio, Paola
    Ardissone, Anna
    Pasanisi, Barbara
    Vita, Giuseppe
    Mongini, Tiziana
    Moggio, Maurizio
    Comi, Giacomo Pietro
    Mercuri, Eugenio
    Bertini, Enrico
    NEUROMUSCULAR DISORDERS, 2017, 27 (05) : 447 - 451
  • [22] Muscle function and age are associated with loss of bone mineral density in Duchenne muscular dystrophy
    Del Rocio Cruz-Guzman, Oriana
    Rodriguez-Cruz, Maricela
    Almeida-Becerril, Tomas
    Maldonado-Hernandez, Jorge
    Wong Baeza, Carlos
    MUSCLE & NERVE, 2019, 59 (04) : 417 - 421
  • [23] Use of Skeletal Muscle MRI in Diagnosis and Monitoring Disease Progression in Duchenne Muscular Dystrophy
    Finanger, Erika L.
    Russman, Barry
    Forbes, Sean C.
    Rooney, William D.
    Walter, Glenn A.
    Vandenborne, Krista
    PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA, 2012, 23 (01) : 1 - +
  • [24] Visualizing ambulatory performance by age and rates of decline among patients with Duchenne muscular dystrophy
    Mayhew, Anna G.
    Signorovitch, James
    Johnson, Michaela
    Frean, Molly
    Ward, Susan J.
    Posner, Nate
    Merla, Valeria
    Mahn, Matthias
    Stimpson, Georgia
    Guglieri, Michela
    Straub, Volker
    Muni-Lofra, Robert
    Manzur, Adnan
    Baranello, Giovanni
    Muntoni, Francesco
    North Star Clinical Network
    JOURNAL OF NEUROMUSCULAR DISEASES, 2025,
  • [25] Effects of AFO Use on Walking in Boys With Duchenne Muscular Dystrophy: A Pilot Study
    Townsend, Elise L.
    Tamhane, Himani
    Gross, K. Douglas
    PEDIATRIC PHYSICAL THERAPY, 2015, 27 (01) : 24 - 29
  • [26] Use of the experience sampling method in adolescents with Duchenne muscular dystrophy: a feasibility study
    Lionarons, Judith M.
    Delespaul, Philippe A. E. G.
    Hellebrekers, Danique M. J.
    Broen, Martinus P. G.
    Klinkenberg, Sylvia
    Faber, Catharina G.
    Hendriksen, Jos G. M.
    Vles, Johan S. H.
    EUROPEAN CHILD & ADOLESCENT PSYCHIATRY, 2024, 33 (07) : 2281 - 2290
  • [27] Viltolarsen in Japanese Duchenne muscular dystrophy patients: A phase 1/2 study
    Komaki, Hirofumi
    Takeshima, Yasuhiro
    Matsumura, Tsuyoshi
    Ozasa, Shiro
    Funato, Michinori
    Takeshita, Eri
    Iwata, Yasuyuki
    Yajima, Hiroyuki
    Egawa, Yoichi
    Toramoto, Takuya
    Tajima, Masaya
    Takeda, Shinichi
    ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2020, 7 (12): : 2393 - 2408
  • [28] Newborn screening for Duchenne muscular dystrophy in China: follow-up diagnosis and subsequent treatment
    Ke, Qing
    Zhao, Zheng-Yan
    Griggs, Robert
    Wiley, Veronica
    Connolly, Anne
    Kwon, Jennifer
    Qi, Ming
    Sheehan, Daniel
    Ciafaloni, Emma
    Howell, R. Rodney
    Furu, Petra
    Sazani, Peter
    Narayana, Arvind
    Gatheridge, Michele
    WORLD JOURNAL OF PEDIATRICS, 2017, 13 (03) : 197 - 201
  • [29] Brazilian consensus on Duchenne muscular dystrophy. Part 1: diagnosis, steroid therapy and perspectives
    Araujo, Alexandra P. Q. C.
    de Carvalho, Alzira A. S.
    Cavalcanti, Eduardo B. U.
    Saute, Jonas Alex M.
    Carvalho, Elmano
    Franca Junior, Marcondes C.
    Martinez, Alberto R. M.
    Navarro, Monica de M. M.
    Nucci, Anamarli
    de Resende, Maria Bernadete D.
    Goncalves, Marcus Vinicius M.
    Gurgel-Giannetti, Juliana
    Scola, Rosana H.
    Sobreira, Claudia F. da R.
    Reed, Umbertina C.
    Zanoteli, Edmar
    ARQUIVOS DE NEURO-PSIQUIATRIA, 2017, 75 (08) : 104 - 113
  • [30] The frequency of Duchenne muscular dystrophy/Becker muscular dystrophy and Pompe disease in children with isolated transaminase elevation: results from the observational VICTORIA study
    Kansu, Aydan
    Kuloglu, Zarife
    Tumgor, Gokhan
    Taskin, Didem Gulcu
    Dalgic, Buket
    Caltepe, Gonul
    Demiroren, Kaan
    Dogan, Guzide
    Kirsaclioglu, Ceyda Tuna
    Arslan, Duran
    Isik, Ishak Abdurrahman
    Demir, Hulya
    Bekem, Ozlem
    Sahin, Yasin
    Bayrak, Nevzat Aykut
    Selimoglu, Mukadder Ayse
    Yavuz, Sibel
    Taskaya, Ibrahim Ethem
    Altay, Derya
    FRONTIERS IN PEDIATRICS, 2023, 11